The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases
Cardio-cerebrovascular disease, related to high mortality and morbidity worldwide, is a type of cardiovascular or cerebrovascular dysfunction involved in various processes. Therefore, it is imperative to conduct additional research into the pathogenesis and new therapeutic targets of cardiovascular...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1132884/full |
| _version_ | 1811155572495482880 |
|---|---|
| author | Jing Li Wenxiu Liu Fu Peng Fu Peng Xiaoyu Cao Xiaofang Xie Cheng Peng |
| author_facet | Jing Li Wenxiu Liu Fu Peng Fu Peng Xiaoyu Cao Xiaofang Xie Cheng Peng |
| author_sort | Jing Li |
| collection | DOAJ |
| description | Cardio-cerebrovascular disease, related to high mortality and morbidity worldwide, is a type of cardiovascular or cerebrovascular dysfunction involved in various processes. Therefore, it is imperative to conduct additional research into the pathogenesis and new therapeutic targets of cardiovascular and cerebrovascular disorders. Long non-coding RNAs (lncRNAs) have multiple functions and are involved in nearly all cellular biological processes, including translation, transcription, signal transduction, and cell cycle control. LncR-Meg3 is one of them and is becoming increasingly popular. By binding proteins or directly or competitively binding miRNAs, LncR-Meg3 is involved in apoptosis, inflammation, oxidative stress, endoplasmic reticulum stress, epithelial-mesenchymal transition, and other processes. Recent research has shown that LncR-Meg3 is associated with acute myocardial infarction and can be used to diagnose this condition. This article examines the current state of knowledge regarding the expression and regulatory function of LncR-Meg3 in relation to cardiovascular and cerebrovascular diseases. The abnormal expression of LncR-Meg3 can influence neuronal cell death, inflammation, apoptosis, smooth muscle cell proliferation, etc., thereby aggravating or promoting the disease. In addition, we review the bioactive components that target lncR-Meg3 and propose some potential delivery vectors. A comprehensive and in-depth analysis of LncR-Meg3’s role in cardiovascular disease suggests that targeting LncR-Meg3 may be an alternative therapy in the near future, providing new options for slowing the progression of cardiovascular disease. |
| first_indexed | 2024-04-10T04:35:29Z |
| format | Article |
| id | doaj.art-bfb541a60bdb4012809045bdbcb4076f |
| institution | Directory Open Access Journal |
| issn | 1664-8021 |
| language | English |
| last_indexed | 2024-04-10T04:35:29Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Genetics |
| spelling | doaj.art-bfb541a60bdb4012809045bdbcb4076f2023-03-10T04:21:47ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-03-011410.3389/fgene.2023.11328841132884The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseasesJing Li0Wenxiu Liu1Fu Peng2Fu Peng3Xiaoyu Cao4Xiaofang Xie5Cheng Peng6Key Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaKey Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaKey Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Pharmacology, Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, ChinaKey Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaKey Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaKey Laboratory of Southwestern Chinese Medicine Resources, Key Laboratory of standardization of Chinese herbal medicine of MOE, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaCardio-cerebrovascular disease, related to high mortality and morbidity worldwide, is a type of cardiovascular or cerebrovascular dysfunction involved in various processes. Therefore, it is imperative to conduct additional research into the pathogenesis and new therapeutic targets of cardiovascular and cerebrovascular disorders. Long non-coding RNAs (lncRNAs) have multiple functions and are involved in nearly all cellular biological processes, including translation, transcription, signal transduction, and cell cycle control. LncR-Meg3 is one of them and is becoming increasingly popular. By binding proteins or directly or competitively binding miRNAs, LncR-Meg3 is involved in apoptosis, inflammation, oxidative stress, endoplasmic reticulum stress, epithelial-mesenchymal transition, and other processes. Recent research has shown that LncR-Meg3 is associated with acute myocardial infarction and can be used to diagnose this condition. This article examines the current state of knowledge regarding the expression and regulatory function of LncR-Meg3 in relation to cardiovascular and cerebrovascular diseases. The abnormal expression of LncR-Meg3 can influence neuronal cell death, inflammation, apoptosis, smooth muscle cell proliferation, etc., thereby aggravating or promoting the disease. In addition, we review the bioactive components that target lncR-Meg3 and propose some potential delivery vectors. A comprehensive and in-depth analysis of LncR-Meg3’s role in cardiovascular disease suggests that targeting LncR-Meg3 may be an alternative therapy in the near future, providing new options for slowing the progression of cardiovascular disease.https://www.frontiersin.org/articles/10.3389/fgene.2023.1132884/fullLncR-Meg3mechanismsclinical applicationcardiovascular diseasescerebrovascular diseases |
| spellingShingle | Jing Li Wenxiu Liu Fu Peng Fu Peng Xiaoyu Cao Xiaofang Xie Cheng Peng The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases Frontiers in Genetics LncR-Meg3 mechanisms clinical application cardiovascular diseases cerebrovascular diseases |
| title | The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases |
| title_full | The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases |
| title_fullStr | The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases |
| title_full_unstemmed | The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases |
| title_short | The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases |
| title_sort | multifaceted biology of lncr meg3 in cardio cerebrovascular diseases |
| topic | LncR-Meg3 mechanisms clinical application cardiovascular diseases cerebrovascular diseases |
| url | https://www.frontiersin.org/articles/10.3389/fgene.2023.1132884/full |
| work_keys_str_mv | AT jingli themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT wenxiuliu themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT fupeng themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT fupeng themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT xiaoyucao themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT xiaofangxie themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT chengpeng themultifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT jingli multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT wenxiuliu multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT fupeng multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT fupeng multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT xiaoyucao multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT xiaofangxie multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases AT chengpeng multifacetedbiologyoflncrmeg3incardiocerebrovasculardiseases |